Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Peptide-based anxiolytics: the molecular aspects of heptapeptide Selank biological activity.

Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N.

Protein Pept Lett. 2018 Sep 25. doi: 10.2174/0929866525666180925144642. [Epub ahead of print]

PMID:
30255741
2.

Anticoagulant Effects of Arginine-Containing Peptides of the Glyproline Family (His-Phe-Arg-Trp-Pro-Gly-Pro and Thr-Lys-Pro-Arg-Pro-Gly-Pro) Revealed by Thromboelastography.

Rogozinskaya EY, Lyapina MG.

Bull Exp Biol Med. 2017 Dec;164(2):170-172. doi: 10.1007/s10517-017-3950-4. Epub 2017 Nov 27.

PMID:
29181670
3.

Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells.

Kobylyanskii AG, Zolotarev YA, Andreeva LA, Grivennikov IA, Myasoedov NF.

Bull Exp Biol Med. 2017 Oct;163(6):731-736. doi: 10.1007/s10517-017-3891-y. Epub 2017 Oct 24.

PMID:
29063333
4.

Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress.

Fomenko EV, Bobyntsev II, Kryukov AA, Ivanov AV, Andreeva LA, Myasoedov NF.

Bull Exp Biol Med. 2017 Aug;163(4):415-418. doi: 10.1007/s10517-017-3817-8. Epub 2017 Aug 29.

PMID:
28853100
5.

Tuftsin - Properties and Analogs.

Siebert A, Gensicka-Kowalewska M, Cholewinski G, Dzierzbicka K.

Curr Med Chem. 2017 Nov 17;24(34):3711-3727. doi: 10.2174/0929867324666170725140826. Review.

PMID:
28745220
6.

Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism.

Slominsky PA, Shadrina MI, Kolomin TA, Stavrovskaya AV, Filatova EV, Andreeva LA, Illarioshkin SN, Myasoedov NF.

Dokl Biol Sci. 2017 May;474(1):106-109. doi: 10.1134/S0012496617030048. Epub 2017 Jul 13.

PMID:
28702721
7.

Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons.

Povarov IS, Kondratenko RV, Derevyagin VI, Myasoedov NF, Skrebitsky VG.

Bull Exp Biol Med. 2017 Mar;162(5):640-642. doi: 10.1007/s10517-017-3676-3. Epub 2017 Mar 30.

PMID:
28361410
8.

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.

Filatova E, Kasian A, Kolomin T, Rybalkina E, Alieva A, Andreeva L, Limborska S, Myasoedov N, Pavlova G, Slominsky P, Shadrina M.

Front Pharmacol. 2017 Feb 28;8:89. doi: 10.3389/fphar.2017.00089. eCollection 2017.

9.

Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.

Kasian A, Kolomin T, Andreeva L, Bondarenko E, Myasoedov N, Slominsky P, Shadrina M.

Behav Neurol. 2017;2017:5091027. doi: 10.1155/2017/5091027. Epub 2017 Feb 9.

10.

Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice.

Kolik LG, Nadorova AV, Seredenin SB.

Bull Exp Biol Med. 2016 Nov;162(1):56-59. Epub 2016 Nov 23.

PMID:
27878720
11.

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.

Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P.

Front Pharmacol. 2016 Feb 18;7:31. doi: 10.3389/fphar.2016.00031. eCollection 2016.

12.

[COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.]

Vasil'eva EV, Kondrakhin EA, Salimov RM, Kovalev GI.

Eksp Klin Farmakol. 2016;79(9):3-11. Russian.

PMID:
29787664
13.

[Optimization of the treatment of anxiety disorders with selank].

Medvedev VE, Tereshchenko ON, Kost NV, Ter-Israelyan AY, Gushanskaya EV, Chobanu IK, Sokolov OY, Myasoedov NF.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):33-40. doi: 10.17116/jnevro20151156133-40. Russian.

PMID:
26356395
14.

[Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia].

Medvedeva EV, Dmitrieva VG, Povarova OV, Limborskaia SA, Skvortsova VI, Miasoedov NF, Dergunova LV.

Mol Biol (Mosk). 2014 Mar-Apr;48(2):277-87. Russian.

15.

The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome.

Mjasoedov NF, Andreeva LA, Grigorjeva ME, Obergan TY, Shubina TA, Lyapina LA.

Dokl Biol Sci. 2014 Sep;458:267-70. doi: 10.1134/S0012496614050020. Epub 2014 Nov 5. No abstract available.

PMID:
25371249
16.

[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].

Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, Kost NV, Sokolov OIu, Miasoedov NF.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(7):17-22. Russian.

PMID:
25176261
17.

Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation.

Kolik LG, Nadorova AV, Kozlovskaya MM.

Bull Exp Biol Med. 2014 May;157(1):52-5. doi: 10.1007/s10517-014-2490-4. Epub 2014 Jun 10.

PMID:
24913576
18.

[Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank].

Kolomin TA, Agapova TIu, Agniullin IaV, Shram SI, Shadrina MI, Slominskiĭ PA, Limborskaia SA, Miasoedov IF.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2013 May-Jun;63(3):365-74. Russian.

PMID:
24450168
19.

The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action.

Kolomin T, Morozova M, Volkova A, Shadrina M, Andreeva L, Slominsky P, Limborska S, Myasoedov N.

Mol Immunol. 2014 Mar;58(1):50-5. doi: 10.1016/j.molimm.2013.11.002. Epub 2013 Nov 27.

PMID:
24291245
20.

[Protective effect of selank on the model of mnestic function violation induced by pharmacological blockade of protein synthesis].

Kozlovskiĭ II, Belozertsev FIu, Andreeva LA, Kozlovskaia MM.

Eksp Klin Farmakol. 2013;76(12):3-7. Russian.

PMID:
24605419

Supplemental Content

Loading ...
Support Center